Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration

NCT03333954 is registered in ClinicalTrials.gov with Science Corporation as lead sponsor.

NCT NCT03333954
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03333954 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility Study of Compensation for Blindness With the PRIMA System in Patients With Dry Age Related Macular Degeneration
Lead sponsor
Science Corporation
Phase
Not applicable
Overall status
Completed
Start date
November 6, 2017
Completion date
December 12, 2024
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

dry age-related macular degeneration